ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SLS SELLAS Life Sciences Group Inc

1.32
-0.03 (-2.22%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
SELLAS Life Sciences Group Inc NASDAQ:SLS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.03 -2.22% 1.32 1.32 1.33 1.37 1.29 1.36 786,873 00:46:32

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, ...

10/04/2014 5:15pm

Business Wire


SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more SELLAS Life Sciences Charts.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc. (“Galena” or the “Company”) (Nasdaq: GALE) securities between November 6, 2013 and February 14, 2014.

For more information, click here: http://zlk.9nl.com/galenabiopharma-gale.

The complaint alleges that throughout the Class Period, Galena made false and/or misleading statements that led to the artificial inflation of Galena’s stock price, allowing its Chief Executive Officer to sell $3.8 million worth of his Galena stock.

On February 12, 2014, an article featured on TheStreet.com alleged Galena was engaging in a misleading campaign aimed at boosting its stock price, alleging that investor relations firm The DreamTeam Group had published articles under aliases promoting the Company’s stock without disclosing their sponsorship. Then on February 14, 2014, Galena acknowledged that it had paid the investor relations firm The DreamTeam Group to promote the Company.

If you suffered a loss in Galena you have until May 5, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/galenabiopharma-gale.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: 212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com

1 Year SELLAS Life Sciences Chart

1 Year SELLAS Life Sciences Chart

1 Month SELLAS Life Sciences Chart

1 Month SELLAS Life Sciences Chart

Your Recent History

Delayed Upgrade Clock